Veterinary X-ray Market Worth $651.76 Million By 2026

The global veterinary X-ray market size is expected to reach USD 651.76 million by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.6% during the forecast period. Rising pet adoption is fueling the need for healthcare facilities, and growing penetration of direct (capture) radiography as well as technological advancements in X-ray systems are some key factors driving growth. As per IDEXX Laboratories, there has been an incremental growth of 2.2% in clinical visits per practice for U.S. companion animals in the first quarter of 2019. The aforementioned factors highlight the untapped opportunities for animal diagnostics segment, inclusive of imaging.

X-ray devices help veterinarians and laboratory technicians to diagnose many conditions, including bladder stones & tumors and determine foreign bodies in an animal’s stomach. These devices also assist in locating fractures and internal injuries. Increasing awareness about animal health along with high adoption of advanced technologies is expected to contribute toward market growth over the forecast period. For instance, advancements in digital radiography and rise in awareness about their benefits such as cost-effectiveness and higher efficiency.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/veterinary-x-ray-market

Further key findings from the study suggest:

Computed radiography held a dominant share in 2018 due to increasing adoption in animal health practices
Digital X-ray equipment segment is expected to gain popularity in the coming years owing to user-friendliness and enhanced productivity
The portable segment is anticipated to witness lucrative CAGR over the forecast period due to increase in awareness about its benefits
Small companion animals segment dominated the veterinary X-ray market as of 2018 due to increasing pet adoption along with rising awareness & concern among pet owners
The hospitals and clinics segment held a dominant revenue share owing to rise in patient footfall
North America accounted for a dominant revenue share as of 2018 due to rise in the number of pets and increase in willingness to pay for their healthcare
SOUND; IDEXX Laboratories, Inc.; FUJIFILM Holdings America Corporation, Heska Corporation, and Canon Inc. are some of the major players with broad product portfolios and significant regional presence
Companies are adopting various strategies such as product development, mergers & acquisitions, partnerships, collaborations, and regional expansion to gain a competitive edge in the market.

Payment Security Market Worth $43.76 Billion By 2025

The global payment security market size is expected to reach USD 43.76 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.3% during the forecast period. Rising need for PCI DSS (payment card industry data security standard) compliance and adoption of digital payment mode by consumers are likely to stoke the growth of the market. The payments industry is going through a movement of infrastructure transformation, which is essential to compete efficiently with non-bank trendsetters and address progressing customer requirements.

Over the past few years, major economies have modernized their payment infrastructures and many others are scheduling to upgrade. Digital payments aid merchants in maintaining continuous compliance with PCI DSS, which is further anticipated to bolster the growth of the payment security market. In March 2015, Worldpay noted over 133,000 fraudulent transactions reported, which interpreted stolen card details being used every 20 seconds. Thus, payment security providers help its customer’s systems to protect itself from threats and aim to provide secure businesses by getting them to comply with PCI DSS. Therefore, the payment security market is estimated to be driven by the adoption of PCI DSS compliance.

Fraud detection and prevention solutions hold the largest share in the overall market. These solutions provide various fraud analytics solutions such as big data and predictive analytics. Big data and predictive analytics helps to detect and avoid frauds.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/payment-security-market

Further key findings from the report suggest:

The global payment security market had a valuation of USD 15.79 billion in 2017
Encryption platform emerged as the fastest growing segment over the forecast period
Large enterprises represented the leading segment in terms of organization in 2017 and are projected to generate revenue over USD 29.80 billion by 2025
The education market is poised to witness the highest CAGR of 13.4% over the forecast period
North America was the leading revenue contributor in 2017. Rising number of startups in the retail industry and presence of prominent payment security providers in the region is expected to drive the North America payment security market
Key players include Braintree, CyberSource, Ingenico, and Index among others. These players commanded the leading revenue share in the market in 2017.

Ovarian Cancer Drugs Market Size Worth $4.5 Billion by 2022

The global ovarian cancer drugs market size is expected to be valued at USD 4.5 billion by 2022, as per a new report by Grand View Research, Inc., expanding at a CAGR of 23.7% during the forecast period. The growth of the market is largely driven by factors such as increased adoption of novel drugs and presence of strong pipeline. Rising incidence of ovarian cancer due to growing geriatric population and unhealthy lifestyles is providing an upthrust to the market.

Ovarian cancer accounts for 3.0% of all malignant tumors among women and 6.0% of all femaledeaths due to cancer. Ovarian cancer accounted for 235,200 new cases and 140,000 deaths worldwide in 2016 with the highest incidence being reported in North America and Europe.

Introduction of non-platinum based PARP inhibitors and VEGF inhibitors in second and third-line settings has changed the treatment regime for ovarian cancer dramatically. Several biologic and small-molecule therapies including antibody drug conjugates (ADC) in development are estimated to have a major impact on ovarian cancer treatment spectrum.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ovarian-cancer-drugs-market

Further key findings from the report suggest:

EU5 is projected to be the second largest market with more than 10.0% share in 2022, owing to increasing ovarian cancer incidence and approval of PARP inhibitors
Key players in the industry are focusing on collaborations for development, broader product portfolios, and regional expansion in emerging markets to increase their market share
Combination regimens and pipeline breakthroughs, specifically those including checkpoint inhibitors such as Roche’s Tecentriq and Pfizer’s Bavencio, are poised to be the upcoming milestones for ovarian cancer treatment
PARP inhibitors are anticipated to be the fastest growing drug class in the ovarian cancer market through the forecast period. Factors such as continued uptake of approved PARP inhibitors owing to their superior efficacy, long treatment duration, and considerable number of treatment opportunities in first-line advanced settings are likely to propel the growth of the drug class.
Although angiogenesis inhibitors accounted for the majority of shares in the market in 2016, the drug class is expected to capture a marginal share in 2022 owing to increasing competition from PARP inhibitors and novel pipeline products
Out of 78 drugs in the pipeline for ovarian cancer, 11 drugs are in Phase III, 29 in Phase II and the remaining in Phase I and pre-clinical trials
A greater understanding of tumor microenvironment is estimated to occur, which would further drive successful development of new patient-specific therapies through the forecast period
Late-stage pipeline includes novel drugs such as ImmunoGen’s mirvetuximab soravtansine and Vascular Biogenics’ VBL-111.

Artificial Urinary Sphincters Market Size Worth $643.4 Million By 2026

The global artificial urinary sphincters market size is anticipated to reach USD 643.4 million by 2026, expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. Increasing prevalence of urinary incontinence (UI), rising healthcare expenditure, and technological advancements in artificial urinary sphincters is anticipated to boost the market growth.

As per European Association of Urology, UI affects around 200 million people worldwide. Stress and urge incontinences are the major diseases affecting older women due to the hormonal changes during menopause. According to The Canadian Continence Foundation, the total cost of UI and fecal incontinence is around USD 4.0 billion annually. Artificial urinary sphincter is one of the safest and most reliable treatments for incontinence. In addition, in 2014, around 3.5 million people in Canada had suffered from some type of incontinence. Thus, increasing prevalence of UI is expected to drive the artificial urinary sphincters market growth.

Government spending on healthcare is increasing faster in developing countries than rest of the global economy. In the middle income countries, government per capita healthcare expenditure has doubled since 2000. According to the WHO, government spends around USD 60 on per person health in the lower middle-income countries whereas USD 270 in upper middle-income countries, which reduces inequities and stimulates economic growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/artificial-urinary-sphincters-market

Further key findings from the report suggest:

Based on the brand, AMS 800 dominated the market in 2018 as it is highly durable, effective, and safe surgical option for the treatment of stress UI in males, and high satisfaction rate among men
The female segment is expected to exhibit the highest CAGR owing to increasing prevalence of UI and fecal incontinence, and increasing awareness about artificial sphincters among women
North America dominated the artificial urinary sphincters market with the highest revenue share in 2018 owing to increasing number of UI cases coupled with growing public awareness to prevent urinary diseases and favorable reimbursement framework in the region
The key players are introducing technologically enhanced products to gain competitive advantage in the industry. For instance, Boston Scientific launched AMS 800 Urinary Control System, to treat stress UI in males. This launch has enhanced Urology and Pelvic Health segment of Boston Scientific Corporation

Exoskeleton Market Size Worth $4.2 Billion By 2027

The global exoskeleton market size is anticipated to reach USD 4.2 billion by 2027, expanding at a CAGR of 26.3% over the forecast period, according to a new report by Grand View Research, Inc. Growing adoption of exoskeletons in healthcare and non-healthcare settings, reimbursement coverage offered on these systems, and increasing prevalence of spinal cord injuries (SCIs) are the key factors driving the market. Moreover, development in robotics and growing demand for customized exoskeleton that addresses the specific needs of the patients is anticipated to fuel the growth over the forecast period.

Based on technology type, in 2019, mobile exoskeleton dominated the global market, accounting for a revenue share of 61.8%. Introduction of innovative mobile exoskeleton by manufacturers for the aging and disabled population is a key factor driving the market. However, mobile systems are complicated and expensive to design, which increases their cost. This is compelling the patients to switch to the stationary systems, thus making stationary systems the fastest growing segment in the market.

On the basis of technology drive type, in 2019, electric actuators dominated the global exoskeleton market with a share of 32.1% in terms of revenue, as they are cost-effective in comparison with the other drive types. Moreover, presence of a wide variety of commercialized electric actuators is fueling the growth of this electric actuators segment. Usage of fuel cell-powered exoskeleton is increasing in military applications as they provide longer operation hours. This is anticipated to drive the fuel cell segment over the forecast period.

North America dominated the global market in 2019, generating a revenue of USD 297.8 million. Increasing investments in robotics, growing geriatric population, favorable reimbursement policies, and availability of funding for various projects are anticipated to drive the regional market over the forecast period. Asia Pacific is expected to exhibit the fastest CAGR owing to growing geriatric population, improvement in the healthcare infrastructure, and increasing investments in robotics in countries, such as Japan, China, and India.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/exoskeleton-market

Further key findings from the report suggest:

The global exoskeleton market size is anticipated to reach USD 4.2 billion by 2027 owing to rising applications of these products in healthcare and non-healthcare settings
Based on technology type, mobile exoskeleton accounted for a major share of 61.8% in 2019 owing to introduction of innovative mobile systems for various industrial applications
On the basis of technology drive type, electric actuators dominated the global market with a revenue share of 32.1% as they are cost-effective than other drive types
North America dominated the market with a value of USD 297.8 million in 2019 owing to availability of favorable reimbursement policies and increasing investments in robotics
Some of the key players operating in this market are Ekso Bionics, Cyberdyne, ReWalk Laboratories, REX Bionics, and Suit X.

Wound Care Market Size Worth $25.1 Billion By 2026

The global wound care market size is expected to reach USD 25.1 billion by 2026, according to a new report by Grand View Research, Inc., registering a 3.9% CAGR during the forecast period. Increase in prevalence of chronic diseases globally, rising number of ambulatory surgical centers (ASCs), and growing geriatric population are key factors driving the global market.

ASCs offer a variety of services such as surgical assistance, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, and gastro intestinal (GI) conditions are also performed in ambulatory surgery centers. Earlier, ASCs were only capable of performing GI-related minor surgeries; however, with increase in number of minimally invasive surgical procedures, services offered by ambulatory surgical centers have expanded and grown exponentially.

According to the U.S. Department of Health and Human Services (HHS) data records of 2014, there were 17.2 million hospital visits. These included invasive, therapeutic surgeries, and ambulatory surgeries. Around 9.94 million (57.8%) of these surgeries occurred in hospital-owned ambulatory surgery settings and the remaining 7.26 million surgeries (42.2%) were conducted in hospitals. ASCs are increasing in number and thus offer cost-effective services. In addition, favorable reimbursement coverages are being provided with regard to services provided by ASCs. The chances of contracting post-surgical, hospital-related infections are also reduced. ASCs provide specific instructions to patients regarding post-surgical homecare. Thus, with an increase in the number of ASCs and number of surgical procedures, demand for wound care is expected to increase.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wound-care-market

Further key findings from the report suggest:

In terms of revenue, the advanced dressing segment held the largest share in 2018 owing to increasing cases of chronic diseases and rising adoption of advanced wound care products across the globe
The home healthcare segment is expected to witness the fastest growth over the forecast period due to increasing geriatric population and rising adoption of negative pressure wound therapy
On the basis of application, the acute segment held the largest wound care market share in 2018 owing to rising number of surgeries and burn cases across the globe
Asia Pacific is expected to witness the fastest growth over the forecast period owing to increasing number of surgeries and rising cases of burns in this region
Prominent key players present in the wound care market include Smith and Nephew; Molnlycke Health Care AB; and Baxter International Inc.

Healthcare Analytics Market Size Worth $53.65 Billion By 2025

The global healthcare/medical analytics market is expected to reach USD 53.65 billion by 2025, according to a new report by Grand View Research, Inc. Increasing need to reduce healthcare expenditure among hospitals, and other healthcare providers is anticipated to boost growth in the market.

With the advent of data-enriched tools such as mHealth, eHealth, Electronic Health Records (EHR), and mobile applications, the communication gap between caregivers and patients has reduced. These tools generate tremendous data, which can be used for personalized treatments.

Generally, patients may hesitate to use these tools, which might affect the implementation of analytics. However, with the combination of artificial and human intelligence data analytics, which offer wide opportunities to further customize medical approaches, the demand for these tools is anticipated to increase over the forecast period.

Hospitals are now using healthcare analytics to manage the number of workers working in a particular shift, for instance, a hospital in Paris uses healthcare analytics to predict the number of patients that may be hospitalized. This data can be used to decide the number of staff members that will be needed for a particular shift, which helps in reducing labor cost in hospitals.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the report suggest:

Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations.
The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered.
The hardware systems category dominated the component segment, high-cost of the hardware contribute to its growth.
On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015.
Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.
Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate.
North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.
The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.
Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.

Digital Health Market Size Worth $509.2 Billion By 2025

The global digital health market size is expected to reach USD 509.2 billion by 2025, expanding at a CAGR of 27.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing adoption of mHealth technologies by physicians to prescribe for self-management of chronic illness, such as diabetes, has propelled the growth of the market. For instance, Glooko is specifically used for management of diabetes. Availability of such apps in smartphones makes it easier for healthcare professionals to access patient information and diagnose diseases. Furthermore, increase in penetration of smartphones and internet connectivity are the key factors driving the market.

Growing need for improving workflow efficiency in hospitals and other healthcare centers is propelling the demand for mHealth services in healthcare administration. For instance, Results SMS in Uganda is an open source SMS-based platform providing appointment reminders. It gives appointment reminders as SMS to patients. In addition, mHealth services are disseminating essential medical information to healthcare professionals, which, in turn, is driving their adoption in healthcare communities as these help in training, updating, and educating about diagnosis and treatment.

Additionally, increasing pressure from the governments to reduce cost and rising demand for improved patient care are resulting in an increase in the demand for electronic health record (EHR) system. Recent advancements in EHR technology with the inclusion of interoperability, mobile, cloud, and big data are propelling the demand for advanced EHRs in the market. Companies are increasingly investing in developing innovative technologies in EHRs, which, in turn, is expected to boost demand in the market. For instance, in 2018, Allscripts launched Avenel, which is a mobile-first, cloud based EHR that uses machine learning to reduce time in clinical documentation and works more like an app.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/digital-health-market

Further Key Findings from the Study Suggest:

In 2018, the mHealth technology segment held the largest revenue share owing to rising adoption of mHealth technologies among physicians and patients, increasing trend of preventive healthcare, and rising funding for mHealth startups
Digital health systems occupied the second largest revenue share in 2018 owing to rising government initiatives to promote digital health, resulting in an increased adoption of digital systems among healthcare systems
North America held the largest revenue share in 2018 owing to rapid growth in adoption of smartphones, advancements in coverage networks, rise in the prevalence of chronic diseases, and increase in geriatric population
Asia Pacific is expected to expand at the fastest CAGR over the forecast period owing to increasing penetration of smartphones and smart wearable devices and rising adoption of mHealth services
Key players operating in the digital health market include Apple Inc.; AirStrip Technologies; Allscripts; Google Inc.; Orange; Qualcomm Technologies Inc.; Mqure; Samsung Electronics Co. Ltd.; Telefonica S.A.; Vodafone Group; Cerner Corporation; and McKesson Corporation.

Clinical Trials Market Size Worth $69.9 Billion By 2027

The global clinical trials market size is expected to reach USD 69.9 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to exhibit a CAGR of 5.1% during the forecast period. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and other products. Also, clinical trials have become increasingly costly ventures, adding to the overall cost of developing a drug. Hence, big pharmaceuticals as well as small biotechnology firms are looking for innovative ways to improve trial outcomes and decrease trial costs.

The increasing need to develop new therapeutics for chronic diseases such as cancer, respiratory disorder, diabetes, cardiovascular disease, and others is creating immense pressure on healthcare. The global pandemic caused due to COVID-19 (coronavirus) and the increasing demand for developing a suitable treatment for the same is driving the market growth. The number of people affected by the coronavirus has reached one million, which further depicts an increasing need for therapeutics and vaccines. Currently, there are 288 therapeutics and 106 vaccines in development. Out of this, nearly 7.0% therapeutics are in Phase IV, 21.0% in Phase III, 43.0% & 13.0% in Phase II & Phase I respectively.

The pandemic has also resulted in global disruption of traditional onsite clinical trials. Hence, the regulatory bodies all over the world have launched various initiatives for fast-tracking clinical trials for the development of innovative solutions. One such instance is Solidarity, an international clinical trial launched by the World Health Organization (WHO) to find effective treatment against COVID-19.

Though COVID-19 is forcing many medical device & drug developers to revise the approach they prepare for these types of crises, integrating best practices within clinical trial procedures and adapting to virtual trials can support continuous development of therapeutics even in the presence of this pandemic.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/global-clinical-trials-market

Further key findings from the study suggest:

Phase III clinical trials dominated the market with a revenue share of 53.0% in 2019. This is attributed to the complexity level associated with this phase
Interventional design segment accounted for the largest market share of 45.6% in 2019 in the study design segment owing to the increasing demand for the intervention for clinical trials by researchers
North America held 51.2% of market share in 2019. Favorable government initiatives and presence of large numbers of players in U.S. offerings advanced services are responsible for the growth
Asia Pacific is expected to expand at the fastest CAGR of 6.1% over the forecast period owing to the increasing patient pool and cost efficient services

Harmonic Filters Market Size Worth $1.28 Billion By 2025

The global harmonic filters market size is estimated to reach USD 1.28 Billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 7.1% during the forecast period. Harmonic filters are an integral part of electric power systems that are used for mitigation of harmonics, an effect produced due to non-linear loads. Significant investments in building renewable energy infrastructure worldwide coupled with the rapid adoption of variable frequency drives (VFDs) for industrial applications such as heating, ventilation, and air conditioning (HVAC) and electric motors are anticipated to boost the growth of the market.

Harmonic filter is an essential component integrated into power converters and inverters, UPS systems, and other commercial applications such as data centers, hospitals, and offices to enhance power quality in these systems. The global demand for the product is projected to rise tremendously by 2030 on account of increasing investments by governments in the deployment of renewable energy infrastructure (wind energy and solar energy).

For instance, China invested approximately USD 126 Billion on renewable energy infrastructure in 2017. Harmonic resonance is a key concern during the set-up of large solar and wind power plants. Harmonic filters are installed during the deployment of renewable energy infrastructure for the purpose of mitigating harmonic disturbances and power losses.

Additionally, key market players are focusing on developing new innovative products for the rapidly growing e-mobility market across the world. For instance, in 2017, Schaffner Holding AG introduced a new lightweight active harmonic filter for electric vehicles with the objective of delivering high performance and reducing power losses even at a high frequency. Moreover, the strong adoption of harmonic filters in the manufacturing and consumer electronics industry coupled with significant renewable energy investments enabled the Asia Pacific regional market to gain a substantial share in 2017.

Increasing investments aimed at the construction of new data centers and renewable energy infrastructure in key countries such as the U.S., China, India, and the U.K. are poised to drive the market over the forecast period. Despite all these benefits, lack of product awareness among small and medium-sized manufacturers coupled with significant availability of substitute products is likely to inhibit the growth of the global harmonic filters market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/harmonic-filter-market

Further key findings from the report suggest:

In 2017, Asia Pacific represented the leading share in the market, owing to the high adoption of VFDs in the manufacturing industry, data centers, and the energy & power sectors
Europe is expected to reflect the highest growth during the forecast period on account of increasing investments in the deployment of renewable energy infrastructure along with burgeoning demand for harmonic filters from the automotive industry, specifically for their use in electric vehicles
Significant investments in R&D initiatives to develop new and innovative harmonic filters with the objective of reducing the overall input voltage and enhancing product performance is estimated to stimulate the growth of the market
Investments aimed at building new data centers to meet the needs of business enterprises are anticipated to stir up the adoption of harmonic filters over the forecast period.